Onconetix, Inc. Files 8-K for Disclosure and Exhibits

Ticker: ONCO · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1782107

Sentiment: neutral

Topics: disclosure, filing

TL;DR

Onconetix (ONCO) filed a routine 8-K for disclosures and exhibits. No major news.

AI Summary

Onconetix, Inc. filed an 8-K on March 19, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio. This filing does not contain specific financial figures or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing serves as a standard corporate disclosure, indicating that Onconetix, Inc. is meeting its reporting obligations with the SEC.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, not indicating any new material events or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Onconetix, Inc.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 19, 2025.

What were the previous names of Onconetix, Inc.?

Onconetix, Inc. was formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc.

In which state is Onconetix, Inc. incorporated?

Onconetix, Inc. is incorporated in Delaware.

What is the principal executive office address for Onconetix, Inc.?

The principal executive office address for Onconetix, Inc. is 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio 45202.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Onconetix, Inc. (ONCO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing